MicroPort Scientific (HK:0853) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
MicroPort Scientific’s affiliate, Shanghai MicroPort Endovascular MedTech (EV MedTech), has reported a significant increase in financial performance for the first half of 2024, with a 26.63% jump in revenue and a 44.60% rise in profit compared to the same period in 2023. These results reflect only EV MedTech’s operations and are not indicative of MicroPort Scientific’s entire group performance. Investors are advised to exercise caution when trading company securities.
For further insights into HK:0853 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue